View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Atezolizumab 840 / Vemurafenib 720 / Cobimetinib 60, Thyroid Cancer, Cycle 2+
Protocol-ID: 2750 V1.0 (Mini), ATEZ840/VEMU720/COBI60, SD, C2+Indication(s)
- Thyroid Cancer (BRAF V600E mutation, anaplastic); ICD-10 C73
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 23.11.2024